Molecular-barcoded deep (>1000X) gene panel sequencing showed enrichment of sSNVs and sIndels in cancer driver genes in AD brain, with recurrent mutations in clonal hematopoiesis genes and up to 40% o

Genetic_Association Score: 0.500 Price: $0.50 Alzheimer's disease in_vivo Status: extracted

What This Experiment Tests

Genetic_Association experiment designed to assess clinical efficacy targeting cancer driver genes; CSF1R; clonal hematopoiesis genes in in_vivo. Primary outcome: Molecular-barcoded deep (>1000X) gene panel sequencing showed enrichment of sSNVs and sIndels in can

Description

Molecular-barcoded deep sequencing (>1000X coverage); analysis of sSNVs and sIndels in cancer driver genes

TARGET GENE
cancer driver genes; CSF1R; clonal hematopoiesis genes
MODEL SYSTEM
in_vivo
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
clonal hematopoiesis; microglial clonal expansion (MiCE)
SOURCE
pmid_38260600
PRIMARY OUTCOME
Molecular-barcoded deep (>1000X) gene panel sequencing showed enrichment of sSNVs and sIndels in cancer driver genes in AD brain, with recurrent mutations in clonal hematopoiesis genes and up to 40% of microglia carrying pathogenic sSNVs.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease0.827

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.